Two-year outcomes of pro re nata ranibizumab monotherapy for exudative age-related macular degeneration in Japanese patients

PURPOSE: To describe outcomes of intravitreal ranibizumab using a pro re nata regimen for treatment-naive exudative age-related macular degeneration (AMD), in Japanese patients over the first 2 years. METHODS: Clinical records were retrospectively reviewed of 48 eyes of 48 patients with treatment-na...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamamoto, Akiko, Okada, Annabelle A, Sugitani, Atsuhiko, Kunita, Daisuke, Rii, Tosho, Yokota, Reiji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Case Series
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3633548/
https://www.ncbi.nlm.nih.gov/pubmed/23620657
http://dx.doi.org/10.2147/OPTH.S42189

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3633548/
https://www.ncbi.nlm.nih.gov/pubmed/23620657
http://dx.doi.org/10.2147/OPTH.S42189

Ejemplares similares